Synopsys Inc
SWB:SYP
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
325.45
560
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
SYP
stock under the Base Case scenario is
300.02
EUR.
Compared to the current market price of 393.55 EUR,
Synopsys Inc
is
Overvalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Synopsys Inc.
| IL |
|
Sapiens International Corporation NV
NASDAQ:SPNS
|
|
| US |
|
Ezenia! Inc
OTC:EZEN
|
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
|
| DE |
|
SAP SE
XETRA:SAP
|
|
| US |
|
Salesforce Inc
NYSE:CRM
|
|
| US |
|
Applovin Corp
NASDAQ:APP
|
|
| US |
|
Intuit Inc
NASDAQ:INTU
|
|
| US |
|
Adobe Inc
NASDAQ:ADBE
|
|
| US |
N
|
NCR Corp
LSE:0K45
|
|
| US |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
A broad slowdown in semiconductor capital spending and potential inventory oversupply could dampen Synopsys’ EDA tool licensing growth, pressuring topline results and halting share gains.
Competition from Cadence, Siemens EDA (Mentor), and emerging specialized design software could intensify client price negotiations, eroding Synopsys’ pricing power and market share.
Rising R&D expenditures to keep pace with advanced process nodes may compress margins if increased costs outstrip possible price premiums, weakening profit growth.
As a market leader in EDA tools with expansive—and typically sticky—client relationships, Synopsys maintains pricing leverage and high renewal rates, reinforcing stable revenue streams.
Structural tailwinds from AI, 5G, and cloud-driven demand for complex chip designs bolster Synopsys’ core software offerings, potentially sustaining robust long-term license growth.
Synopsys’ broadening portfolio—particularly in IP licensing and software security solutions—opens cross-selling opportunities, driving incremental growth beyond traditional chip design markets.
Revenue & Expenses Breakdown
Synopsys Inc
Balance Sheet Decomposition
Synopsys Inc
| Current Assets | 5.6B |
| Cash & Short-Term Investments | 2.6B |
| Receivables | 2.2B |
| Other Current Assets | 787.6m |
| Non-Current Assets | 42.6B |
| PP&E | 1.4B |
| Intangibles | 40B |
| Other Non-Current Assets | 1.2B |
| Current Liabilities | 3.4B |
| Accounts Payable | 132.9m |
| Accrued Liabilities | 1.3B |
| Other Current Liabilities | 2.1B |
| Non-Current Liabilities | 17.2B |
| Long-Term Debt | 14.3B |
| Other Non-Current Liabilities | 2.9B |
Free Cash Flow Analysis
Synopsys Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Synopsys Inc
|
Revenue
|
6.4B
USD
|
|
Cost of Revenue
|
-1.3B
USD
|
|
Gross Profit
|
5.1B
USD
|
|
Operating Expenses
|
-4B
USD
|
|
Operating Income
|
1.1B
USD
|
|
Other Expenses
|
893.3m
USD
|
|
Net Income
|
2B
USD
|
SYP Profitability Score
Profitability Due Diligence
Synopsys Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Synopsys Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
SYP Solvency Score
Solvency Due Diligence
Synopsys Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Score
Synopsys Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SYP Price Targets Summary
Synopsys Inc
According to Wall Street analysts, the average 1-year price target for
SYP
is 487 EUR
with a low forecast of 369.1 EUR and a high forecast of 568.8 EUR.
Dividends
Current shareholder yield for
SNPS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SYP
stock under the Base Case scenario is
300.02
EUR.
Compared to the current market price of 393.55 EUR,
Synopsys Inc
is
Overvalued by 24%.